Trials / Conditions / Ovarian Endometrioid Tumor

Ovarian Endometrioid Tumor

6 registered clinical trials studyying Ovarian Endometrioid Tumor.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Ca NCT05226507	Nuvectis Pharma, Inc.	Phase 1
Withdrawn	Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer NCT04510584	University Health Network, Toronto	Phase 2
Completed	Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ova NCT03685695	Roswell Park Cancer Institute	Phase 2
Active Not Recruiting	Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ova NCT02627443	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared NCT02446600	National Cancer Institute (NCI)	Phase 3
Completed	Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mas NCT02520115	Barbara Ann Karmanos Cancer Institute	Phase 1